Granulomatosis with polyangiitis epidemiology and demographics
|
Granulomatosis with polyangiitis Microchapters |
|
Differentiating Granulomatosis with polyangiitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Granulomatosis with polyangiitis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Granulomatosis with polyangiitis epidemiology and demographics |
|
FDA on Granulomatosis with polyangiitis epidemiology and demographics |
|
CDC on Granulomatosis with polyangiitis epidemiology and demographics |
|
Granulomatosis with polyangiitis epidemiology and demographics in the news |
|
Blogs on Granulomatosis with polyangiitis epidemiology and demographics |
|
Directions to Hospitals Treating Granulomatosis with polyangiitis |
|
Risk calculators and risk factors for Granulomatosis with polyangiitis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Overview
The prevalence of Granulomatosis with polyangiitis is 34.3 cases per million per year, with higher prevalence rates found in northern European countries such as Norway, southern Sweden, northern Germany and the United Kingdom. The incidence of the disease is 2.4 cases per million per year, with higher incidences found in Norway, Sweden, Germany, and the United Kingdom.
Epidemiology
Age
Wegener's granulomatosis is most common in middle-aged adults. It is rare in children, but has been seen in infants as young as 3 months old.
Race
Whites are more likely to get it as compared to Blacks. 90% of the patients are white.